Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $461M | $614M | $696M | $692M | $7.37M | $10.3M | $13.7M | $17.5M | $19.2M | $28.2M |
| Revenue growth | — | 33.2% | 13.4% | -0.6% | -98.9% | 39.7% | 33.2% | 27.3% | 9.8% | 47.3% |
| Operating income | $102M | $124M | — | — | — | — | — | — | — | — |
| Operating margin | 22.1% | 20.1% | — | — | — | — | — | — | — | — |
| Net income | $45.9M | $63.9M | $213M | $30.2M | $72.2M | $66.7M | $40.9M | -$278M | -$654M | -$246M |
| Net margin | 10.0% | 10.4% | 30.7% | 4.4% | 980.0% | 647.7% | 298.4% | -1594.5% | -3416.4% | -872.1% |
| EPS (diluted) | $0.33 | $0.34 | $1.02 | $0.14 | $0.52 | $0.45 | $0.15 | -$0.74 | -$1.81 | -$0.71 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $204M | $308M | $337M | $340M | $470M | $233M | $273M | $500M | $502M | $457M |
| Capital expenditures | $43.0M | $64.8M | $77.9M | $91.5M | $74.7M | $97.2M | — | — | — | — |
| Free cash flow | $161M | $243M | $260M | $249M | $395M | $135M | — | — | — | — |
| Share buybacks | $2.64M | $3.41M | $70.3M | $12.2M | $1.44M | $3.80M | $3.19M | $2.30M | $8.88M | $4.01M |
| Dividends paid | $159M | $207M | $253M | $256M | $163M | $175M | $284M | $472M | $458M | $387M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11.2M | $100M | $126M | $32.7M | $115M | $13.2M | $61.0M | $25.7M | $68.9M | $26.2M |
| Total assets | $3.75B | $6.45B | $6.19B | $6.64B | $6.79B | $4.26B | $13.8B | $12.6B | $10.7B | $9.21B |
| Total liabilities | $1.96B | $3.08B | $2.85B | $3.21B | $3.56B | $2.07B | $6.17B | $5.71B | $5.35B | $4.53B |
| Long-term debt | $1.77B | $2.78B | $2.54B | $2.75B | $3.03B | $1.80B | $5.35B | $4.99B | $4.66B | $3.91B |
| Shareholders' equity | $1.69B | $3.28B | $3.26B | $3.36B | $3.17B | $2.19B | $7.57B | $6.82B | $5.23B | $4.62B |
| Shares (wtd avg diluted) | 140M | 185M | 210M | 210M | 134M | 143M | 254M | 379M | 366M | 350M |
Every figure is extracted from Healthcare Realty Trust Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.